(Q49169372)

English

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.

scientific article published on 8 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

1 reference

based on heuristic

inferred from title

cervical intraepithelial neoplasia

1 reference

based on heuristic

inferred from title

object named as

Frank Struyf

29

0 references

object named as

Dan Apter

8

0 references

object named as

Adrian Mindel

24

0 references

Xavier Castellsagué

object named as

Xavier Castellsagué

6

0 references

Jorge Salmerón

object named as

Jorge Salmerón

10

0 references

16

object named as

Anne Szarewski

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

Cosette M Wheeler

3

object named as

Cosette M Wheeler

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

2

object named as

Jorma Paavonen

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

Francesc Xavier Bosch José

26

object named as

F Xavier Bosch

2 references

ORCID Public Data File 2021

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

S. Rachel Skinner

7

object named as

S Rachel Skinner

2 references

ORCID Public Data File 2021

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

Suzanne Marie Garland

5

object named as

Suzanne M Garland

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

9

object named as

Paulo Naud

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

11

object named as

Song-Nan Chow

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

Henry C Kitchener

12

object named as

Henry Kitchener

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

Unnop Jaisamrarn

4

object named as

Unnop Jaisamrarn

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

15

object named as

Genara Limson

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

Barbara Romanowski

17

object named as

Barbara Romanowski

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

18

object named as

Fred Y Aoki

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

Willy A J Poppe

20

object named as

Willy A J Poppe

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

25

object named as

Philippe De Sutter

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

Dominique Descamps

28

object named as

Dominique Descamps

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

HPV PATRICIA Study Group

31

object named as

HPV PATRICIA Study Group

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

author name string

Matti Lehtinen

1

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

Júlio C Teixeira

13

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

James Hedrick

14

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

Tino F Schwarz

19

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

Newton S De Carvalho

21

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

Maria Julieta V Germar

22

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

Klaus Peters

23

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

Marie-Pierre David

27

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

Gary Dubin

30

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

publication date

8 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

13

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

1

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

89-99

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

A controlled trial of a human papillomavirus type 16 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The beginning of the end for cervical cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival of in situ carcinoma of cervix uteri: a 50-year follow-up in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The carcinogenicity of human papillomavirus types reflects viral evolution.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Enrolment of 22,000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: guarding against guessing

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Genital Human Papillomavirus Infection in Female University Students as Determined by a PCR-Based Method

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Health and economic implications of HPV vaccination in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cervical cancer incidence can increase despite HPV vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970286-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(11)70286-8

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/22075171

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49169372&oldid=1856533557"